Pharmacology Flashcards
Pramlintide
Amylin analog. MOA = decrease gastric emptying and decrease glucagon. Used for type 1 + type 2 DM.
Dopamine MOA
At low doses stimulates D1 receptors in the renal vasculature and tubules, thereby increasing GFR, RBF, and sodium excretion. Big heart in middle of room + normal sized christian is squeezing it/at high doses stimulates beta-1 adrenergic receptors in the heart, thereby increasing cardiac contractility + pulse pressure + systolic BP. Huge air force one plane by the left that monster Christian is driving/at highest doses stimulates alpha-1 receptors in the systemic vasculature.
Why do you give dopamine for shock?
To stimulate a1 receptors in the systemic vasculature, causing vasoconstriction.
Amiloride vs. amiodarone vs.
Amiloride –> K+ sparing diuretic.
amiodarone –> K channel blocker
amlodipine –> Ca channel blocker
Ergotamine
o Code: Elisabeth with Erik backpack/ergotamine. Smoking a huge blunt + walking out of air force one/MOA = partial agonist/antagonist activity at tryptaminergic + dopaminergic + alpha-adrenergic receptors. Feet and arms are gangrenous/SE’s = peripheral vascular ischemia + potentially gangrene.
o Location: /usually used for migraines.
How can morphine therapy lead to toxicity?
Morphine is metabolized to active metabolites that accumulate and can cause CNS depression.
Drugs contraindicated in CHF
Diltiazem and verapamil.
Hydralazine MOA
Smooth muscle relaxant and vasodilator in arteries and arterioles. Exact mechanism unclear.
Phenoxybenzamine MOA
Non-selective irreversible alpha blocker
labetalol MOA
Mixed alpha/beta adrenergic antagonist
What is Vmax proportional to?
Enzyme concentration
Relationship of Km to Vmax
Km is enzyme saturation at 1/2Vmax
competitive inhibitor vs. noncompetitive inhibitor
FA 236
What does a change in y-intercept on Lineweaver-Burk plot indicate?
Increased y-intercept = decreased Vmax since y-axis is the reciprocal of Vmax
What does x-intercept represent on lineweaver-Burk plot?
The further to the right (i.e. the closer to zero), the greater the Km and the lower the affinity since x-axis is reciprocal of negative Km.
What is slope on Lineweaver-Burk plot?
Km/Vmax
How do you differentiate competitive inhibitors from noncompetitive on Lineweaver-Burk plot?
Reversible competitive inhibitors cross each other competitively, whereas noncompetitive inhibitors do not.
Competitive inhibitors, reversible
1) resemble substrate?
2) overcome by increased saturation?
3) bind active site?
4) effect on Vmax?
5) effect on Km?
6) potency? efficacy?
1) Yes
2) Yes
3) Yes
4) Unchanged
5) Increased
6) Decreased potency
Competitive inhibitors, IRREVERSIBLE
1) resemble substrate?
2) overcome by increased saturation?
3) bind active site?
4) effect on Vmax?
5) effect on Km?
6) potency? efficacy?
1) Yes
2) No
3) Yes
4) Decreased
5) Unchanged
6) Decreased efficacy
NONcompetitive inhibitors
1) resemble substrate?
2) overcome by increased saturation?
3) bind active site?
4) effect on Vmax?
5) effect on Km?
6) potency? efficacy?
1) No
2) No
3) No
4) Decreased
5) Unchanged
6) Decreased efficacy
What is bioavailability?
Fraction of administered drug reaching systemic circulation unchanged
bioavailability of IV dose of drug
100%
Why is bioavailability usually less than 100%
Incomplete absorption + first pass metabolism
How do liver and kidney disease affect Vd?
Decreased protein binding leads to increased volume of distribution.
Drugs that stick to blood compartment characteristics…
Large/charged molecules; plasma protein bound
Relative Vd of ECF, tissue, Blood compartments
Blood = low
ECF = medium
All tissues including fat = high
Characteristics of drugs that stay in ECF compartment?
Small hydrophilic molecules
Characteristics of drugs that stay in fat/tissue compartment?
Small lipophilic molecules, especially if bound to tissue protein.
Steady state in a drug with first-order kinetics?
Takes 4-5 lives to reach steady state and 3.3 half lives to reach 90% of steady-state.
What happens to maintenance and loading dose with renal or liver disease?
You need need to decrease maintenance dose. Loading dose is usually unchanged.
What does time to steady state depend on?
Primarily half life. Independent of dose and dosing frequency.
Additive drug interaction?
Effect of substance A and B together is equal to the sum of their individual effects.
Example of additive drug interaction
Aspirin + acetaminophen
Permissive drug interaction?
Presence of substance A is required for the full effects of substance B.
Example of permissive drug interaction?
Cortisol on catecholamine responsiveness
synergistic drug interaction?
Effect of substance A and B together is greater than the sum of their individual effects.
Classic example of synergistic drug interaction?
Clopidogrel with aspirin
tachyphylactic drug interaction?
Acute decrease in response to a drug after initial/repeated administration.
classic examples of tachyphylactic drug interactioN?
MDMA and LSD
Graph of plasma concentration of drug vs. time with zero-order elimination?
linear
Drugs with zero-order elimination?
1) phenytoin
2) ethanol
3) aspirin (at high or toxic concentrations)
term for elimination in zero-order elimination?
“Capacity-limited elimination”
What is rate of elimination proportional to in first-order clearance?
Directly proportional to drug concentration (constant fraction eliminated per unit time)
term for elimination in first-order elimination?
“flow-dependent elimination”
Graph of plasma concentration of drug vs. time with first-order elimination?
exponential
Difference between ionized drugs and non-ionized in terms of renal clearance?
Ionized species are trapped in urine and cleared quickly. Neutral forms can be reabsorbed.
Examples of drugs that are weak acids…
1) phenobarbital
2) methotrexate
3) aspirin
Treating overdose for weak acid drugs…
Trapped in basic environments so treat overdose with bicarbonate.
Examples of drugs that are weak bases…
1) amphetamines
2) TCAs
Treating overdose for weak base drugs…
Trapped in acidic environments so treat with ammonium chloride.
Drug metabolism changes with age.
1) Geriatric patients lose phase I metabolism first.
2) More Phase II
What is Phase I metabolism?
Reduction, oxidation, hydrolysis with CYP-450 usually yielding slightly polar, water-soluble metabolites.
Caveat about drugs after Phase 1 metabolism…
Often still active.
What is Phase II metabolism?
Conjugation (MGAS - Methylation, glucuronidation, acetylation, sulfating), usually yields very polar, inactive metabolites (really excreted).
Problem with people who are slow acetylators?
They have increased side effects from certain drugs because of decreased rate of Phase II metabolism.
What is efficacy proportional to?
Vmax
How is potency represented on maximal effect vs. dose graph?
X-axis (EC50), left shift = decreased EC50 = increased potency = decreased drug needed.
partial agonist vs. agonist
partial agonists have lower efficacy.
effect of competitive antagonist
Shifts curve right (decreased potency, no change in efficacy.
effect of NONcompetitive antagonist
Shifts curve down (decreasing efficacy).
phenoxybenzamine MOA
noncompetitive antagonist on alpha receptors
Therapeutic index?
Difference between TD50 and ED50
TD50?
median toxic dose
ED50?
median effective dose
therapeutic window
Dosage range that can safely and effectively treat disease.
How to calculate therapeutic index?
TD50/ED50
Drugs with lower therapeutic indexes?
1) Digoxin
2) Lithium
3) theophylline
4) warfarin
Implication of drugs with low therapeutic indices?
Frequently require monitoring
LD50?
Basically TD50 in animal studies.
Caveat about adrenal medulla and sweat glands
Part of sympathetic nervous system but innervated by cholinergic fibers
Somatic nervous system structure + neurotransmitter
Voluntary motor nerves synapsing on skeletal muscle and release ACh.
Parasympathetic nervous system structure + neurotransmitter
1) Long preganglionics releasing ACh and synapsing on nicotinic receptors
2) short postganglionics releasing ACh and synapsing on muscarinic receptors at target organ
What receives sympathetic innervation?
1) sweat glands
2) cardiac and smooth muscle (both PS and S)
3) gland cells (both PS and S)
4) renal vasculature
5) vessels
Sympathetic vs. parasympathetic nerve structure
1) In parasympathetic, you have long preganglionics and short postganglionics.
2)
Sympathetic pregalgnionics
All release ACh onto Nicotinic receptors.
Sweat gland innervation
Sympathetic. ACh on muscarinic receptors.
Cardiac and smooth muscle, gland cells, nerve terminals innveration in sympathetic
NE synapsing on adrenergic receDptors
Dopamine 1 receptors expressed in…
1) renal vasculature
2) smooth muscle
Adrenal meddle neuromuscular transmission
preganglionics release ACh onto nicotinic receptors in the adrenal medulla. Catecholamines are released into blood. NE acts on A1,A2,B1, Epi on A1,A2, B1,B2
Structure of nicotinic ACh receptors?
Ligand-gated Na+/K+ channels.
Subdivisions of nicotinic receptors and expression
1) Nn (autonomic ganglia + adrenal medulla)
2) Nm (found in NMJ of skeletal muscle)
Muscarinic ACh receptor structure
G-protein-coupled receptors that usually act through 2nd messengers.
A1 functions
1) vascular smooth muscle contraction
2) Increase pupillary dilator muscle contraction (Mydriasis)
3) increase intestinal and bladder sphincter muscle contraction
A2 receptor functions
1) decrease sympathetic (adrenergic) outflow
2) decrease insulin release
3) lipolysis
4) decrease platelet aggregation
5) decrease aqueous humor production
B1 receptor functions
1) increase HR
2) increase contractility
3) increase renin release
4) increase lipolysis
B2 receptor functions
1) vasodilation
2) bronchodilation
3) increased lipolysis
4) increase insulin release
5) decrease uterine tone (tocolysis)
6) ciliary muscle relaxation
7) increase aqueous humor production
beta 3 class
Gs
Beta 3 functions
1) increased lipolysis
2) thermogenesis in skeletal muscle
M1 functions
1) CNS
2) enteric nervous system
M2 class
Gi
M2 functions
1) decrease heart rate
2) decrease contractility of atria
M3 functions
1) exocrine gland secretions (lacrimal, sweat, salivary, gastric acid)
2) increase gut peristalsis
3) increase bladder contraction
4) bronchoconstriction
5) Increase pupillary sphincter muscle contraction (mitosis)
6) ciliary muscle contraction (accommodation)
D1 receptors
Gs
D1 functions
1) relax renal vascular smooth muscle
D2 receptor
Gi
D2 receptor functions
1) modulates transmitter release, especially in brain
H1 receptor g protein class
Gq
H1 receptor function
1) Increase nasal and bronchial mucus production
2) increase vascular permeability
3) contraction of bronchioles
4) pruritus
5) pain
H2 receptor class
Gs
H2 receptor function
1) increase gastric acid secretion
V1 receptor class
Gq
V1 receptor function
Increase vascular smooth muscle contraction
V2 receptor class
Gs
V2 receptor function
1) ADH
Gq pathway
PIP2 (phospholipase C) –> DAG –> PKC
OR
PIP2 (phospholipase C) –> IP3 –> increased calcium concentration –> smooth muscle contraction
Gs/Gi pathway
adenylyl cyclase –> ATP to cAMP –> PKA –> increased calcium in heart OR myosin light-chain kinase (smooth muscle)
Hemicholinium
enzyme that inhibits choline uptake into neurons
vesamicol
enzyme that inhibits ACh uptake into vesicles
Metyrosin MOA
inhibits conversion of tyrosine to DOPA
Reserpine MOA
inhibits dopamine uptake into vesicles
ephedrine cell bio MOA
stimulates release of NE from vesicles
Bretylium MOA
Inhibit NE release from vesicles.
Guanethidine MOA
Inhibit NE release from vesicles. indirect general agonist + releases stored catecholamines, thus activating alpha and beta receptors
How is NE release from sympathetic nerves modulated?
NE regulates itself, by feeding back and acting on presynaptic alpha2 receptors.
How do amphetamines get into presynaptic terminal?
NET transporter (NE transporter) (NET)
How do amphetamines get into vesicles? What happens after?
VMAT, vesicular monoamine transporter. This displace NE from the vesicles. Once NE reaches a concentration threshold within the presynaptic terminal, the action of NET is reversed, and NE is expelled into the synaptic cleft, contributing to the characteristics and effects of increased NE observed in patients taking amphetamines.
Excess tyramine mechanism
It enters presynaptic vesicles and displaces other neurotransmitters (eg, NE) –> increasing amount of active presynaptic neurotransmitters, which diffuse into the synaptic cleft, leading to increased sympathetic simulation and hypertensive crisis.